Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspepsia, Endoscopy upper gastrointestinal tract, Fibromyalgia, Gastritis
Clinical narrative: each covid vaccine+boosters caused a flare-up of my fibromyalgia; The 2nd & 3rd boosters caused heartburn + gastritis; The 2nd & 3rd boosters caused heartburn + gastritis; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 66 years for covid-19 immunisation. The patient's relevant medical history included: "Fibromyalgia CFS", start date: 1993 (ongoing), notes: Pertinent Details (Include surgical procedures and dates): Take medications for sleep and pain.; "Tachycardia", start date: 1995 (ongoing); "Anxiety", start date: 1995 (ongoing); "Heartburn", start date: 2022 (ongoing), notes: Pertinent Details (Include surgical procedures and dates): Heartburn started after receiving 1st COVID booster; "Osteoporosis", start date: 2000 (ongoing); "Sleep" (unspecified if ongoing). The patient's family history included: "Cancer" (unspecified if ongoing); "Heart issues" (unspecified if ongoing); "Alzheimer's" (unspecified if ongoing); "Strokes" (unspecified if ongoing); "Graves' disease" (unspecified if ongoing). Concomitant medication(s) included: AMITRIPTYLINE oral taken for fibromyalgia, start date: 1995 (ongoing); CLONAZEPAM oral taken for anxiety, sleep disorder, start date: 1995 (ongoing); METOPROLOL TARTRATE oral taken for tachycardia, start date: 1995 (ongoing); CELECOXIB oral taken for fibromyalgia, start date: 2021 (ongoing); PANTOPRAZOLE oral taken for dyspepsia, start date: 2022 (ongoing). Vaccination history included: BNT162b2 (Dose: 3rd, Time (24hrs): 10:15, Anatomical Site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot number: FK9729), administration date: 02Feb2022, for Covid-19 immunization, reaction(s): "Heartburn", "gastritis"; BNT162b2 (Dose: 2nd, Time (24hr): 10:30, Anatomical Site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot number: FC3182), administration date: 31Aug2021, for Covid-19 immunization; BNT162b2 (Dose: 1st, Time (24hr): 16:00, Anatomical Site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot number: FA6780), administration date: 10Aug2021, for Covid-19 immunization; Bnt162b2 (3rd booster: FM7553), for Covid-19 immunization. The following information was reported: FIBROMYALGIA (non-serious), outcome "recovered with sequelae", described as "each covid vaccine+boosters caused a flare-up of my fibromyalgia"; DYSPEPSIA (non-serious), GASTRITIS (non-serious), outcome "not recovered" and all described as "The 2nd & 3rd boosters caused heartburn + gastritis". The event "the 2nd & 3rd boosters caused heartburn + gastritis" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of fibromyalgia. Therapeutic measures were taken as a result of dyspepsia, gastritis.  Additional information: Each COVID vaccine and boosters caused a flare-up of my fibromyalgia that started to resolve itself within one week after vaccine shot. The second and third shot boosters caused heartburn and gastritis. Now takes medication for heartburn and gastritis every day. Medication controls it but without medication, heartburn and gastritis comes back. Patient at higher risk for this due to long-term use of anti-inflammatory drugs.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.